{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 0.8,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA), Table 1",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of footnote regarding US-specific screening site procedures."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Alignment of zinc discontinuation duration with other protocol sections."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Operational change allowing US sites to perform screening procedures only to facilitate recruitment."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1",
        "reasonText": "To facilitate participant recruitment across different regions of the US and to lessen inconvenience for participants without compromising the quality of the study.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1",
        "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol.",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Addition of text to the footnote to state that procedures specific to screening sites (only in the US) detailed in Section 8",
        "summary": "Added footnote regarding US-specific screening site procedures in the Schedule of Activities."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed the number of days for zinc's inhibitory effect from 30 to 21 to ensure protocol consistency."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Introduced a provision for US sites to act as screening-only centers to improve recruitment and participant access."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 2,
      "changeCount": 3
    }
  }
}